Long-term Effectiveness of Long-Acting Cabotegravir and Rilpivirine in an Infectious Disease Office-Based HIV Program
Presented at IDWeek 2025
Authors:
Nikhil K. Bhayani, MD, FIDSA
Jorge R. Bernett, MD
Thomas K. Sleweon, MD
Erika M. Young, DO
Kent J. Stock, DO
Stacey E. Baker, MD
Quyen Luu, MD
Brian S. Metzger, MD, MPH
Kimberly A. Couch, PharmD, MA, FIDSA, FASHP
Christina J. Weeks, PharmD
Lucinda J. Van Anglen, PharmD, FIDSA